Christine M. Minnar

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape”.

Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape

Nature Communications(2021)10.1038/s41467-021-25393-x

N/A

0DataRank · unranked

87 citations

Paul L. Chariou, Yohei Ozawa, Christine M. Minnar, Karin M. Knudson, Thomas J. Meyer +5 more

Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfa

OncoImmunology(2021)10.1080/2162402x.2021.1915561

N/A

0DataRank · unranked

6 citations

Kristin C. Hicks, Christine M. Minnar, Karin M. Knudson, Jeffrey Schlom, Sofia R. Gameiro +1 more

Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004561

N/A

0DataRank · unranked

48 citations

Paul L. Chariou, Lucas A. Horn, Kristin C. Hicks, Claudia Palena, Jeffrey Schlom +2 more

Exploiting an Interleukin-15 Heterodimeric Agonist (N803) for Effective Immunotherapy of Solid Malignancies

Cells(2023)10.3390/cells12121611

N/A

0DataRank · unranked

20 citations

Christine M. Minnar, Patrick Soon‐Shiong, Jeffrey Schlom, Sofia R. Gameiro, Grace Lui

Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine

Frontiers in Oncology(2024)10.3389/fonc.2023.1321318

N/A

0DataRank · unranked

26 citations

Grace Lui, James L. Gulley, Jeffrey Schlom, Sofia R. Gameiro, Christine M. Minnar

Systemic immunostimulation induces glucocorticoid-mediated thymic involution succeeded by rebound hyperplasia which is impaired in aged recipients

Frontiers in Immunology(2024)10.3389/fimmu.2024.1429912

N/A

0DataRank · unranked

7 citations

Lam T. Khuat, Gail D. Sckisel, Logan V. Vick, Christine M. Minnar, Cordelia Dunai +14 more

Generation of murine tumor models refractory to αPD-1/-L1 therapies due to defects in antigen processing/presentation or IFNγ signaling using CRISPR/Cas9

PLoS ONE(2024)10.1371/journal.pone.0287733

N/A

0DataRank · unranked

2 citations

Christine M. Minnar, Mayank Tandon, Mary R. Guest, Raj Chari, Jeffrey Schlom +2 more

Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1490

N/A

0DataRank · unranked

2 citations

Carolina Celades, Christine M. Minnar, Asma S. Khelifa, Lisa K. Poppe, Dara Bracken‐Clarke +8 more